Insider Trading Activity Aevi Genomic Medicine, Inc. (NASDAQ:GNMX) – Major Shareholder Bought 20,470 shares of Stock

Insider Trading Activity For Aevi Genomic Medicine, Inc. (NASDAQ:GNMX)

Philip R Harper , Major Shareholder of Aevi Genomic Medicine, Inc. (NASDAQ:GNMX) reportedly Bought 20,470 shares of the company’s stock at an average price of 1.19 for a total transaction amount of $24,359.30 SEC Form

Insider Trading History For Aevi Genomic Medicine, Inc. (NASDAQ:GNMX)

  • On 3/24/2017 Philip R Harper, Major Shareholder, bought 1,058,531 with an average share price of $1.78 per share and the total transaction amounting to $1,884,185.18.View SEC Filing
  • On 4/26/2017 Sol J Barer, Director, bought 100,000 with an average share price of $1.54 per share and the total transaction amounting to $154,000.00.View SEC Filing
  • On 4/28/2017 Sol J Barer, Director, bought 100,000 with an average share price of $1.57 per share and the total transaction amounting to $157,000.00.View SEC Filing
  • On 8/10/2017 Philip R Harper, Major Shareholder, bought 20,470 with an average share price of $1.19 per share and the total transaction amounting to $24,359.30.View SEC Filing
  • Analyst Ratings For Aevi Genomic Medicine, Inc. (NASDAQ:GNMX)
    These are 1 Hold Rating, 1 Buy Rating .
    The current consensus rating for Aevi Genomic Medicine, Inc. (NASDAQ:GNMX) is Buy (Score: 2.50) with a consensus target price of $5.25 , a potential (275.00% upside)

    Analyst Ratings History For Aevi Genomic Medicine, Inc. (NASDAQ:GNMX)

    • On 3/21/2017 Needham & Company LLC Reiterated Rating Buy to Buy with a price target of $12.00 to $9.00
    • On 8/7/2017 Jefferies Group LLC Reiterated Rating Hold with a price target of $1.50

    Recent Trading Activity for Aevi Genomic Medicine, Inc. (NASDAQ:GNMX)
    Shares of Aevi Genomic Medicine, Inc. closed the previous trading session at 1.40 up +0.08 6.46% with 337,410 shares trading hands.

    An ad to help with our costs